Use of recombinant gastric lipase for treating functional dyspepsia
OwnerPatrick Berna, Stephane Milanoinventors
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for treating a functional dyspepsia by administering to a mammal in need thereof a preparation comprising a recombinant gastric lipase. The invention also relates to pharmaceutical compositions comprising a recombinant gastric lipase and methods of use.
Claims15
A method for treating a functional dyspepsia by administering to a mammal in need thereof a preparation comprising a recombinant gastric lipase.
A pharmaceutical preparation comprising a recombinant gastric lipase and a carrier, wherein said preparation comprises from about 7 mg to 660 mg of said recombinant gastric lipase.
A pharmaceutical preparation comprising a recombinant gastric lipase and a carrier, wherein said preparation comprises from about 30 mg to 330 mg of said recombinant gastric lipase.
A pharmaceutical preparation comprising a recombinant dog gastric lipase and a carrier, wherein said preparation comprises from about 7 mg to 660 mg of said recombinant dog gastric lipase.
A pharmaceutical preparation comprising a recombinant dog gastric lipase and a carrier, wherein said preparation comprises from about 30 mg to 330 mg of said recombinant dog gastric lipase.
Dependencies are inferred from the claim text.